Services Overview

State-of-the-art methods for accelerating your drug development.

Preclinical support to ultimately cure patients

Founded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) supporting the preclinical development of drugs. Our mission is to accelerate drug development by offering well-characterized and translational research models and innovative CRO services.

Our Focus

From target validation to preclinical stages of the development pipeline


InnoSer actively guides and supports our customers with a variety of in vivo and in vitro methods backed by niche expertise and therapeutic knowledge.

stages of the preclinical pipeline

Our Pillars

Quality in vitro and in vivo services to fit your project

Drug Development Services

Pharmacology and efficacy studies

  • PK/PD studies
  • Optimal dose determination studies
  • Non-GLP toxicology
  • Biocompatibilty studies
  • 2D/3D cell culture
    • Organoids


  • High content imaging
  • Live cell imaging
  • Bioluminescence imaging
  • Ultrasound
  • Confocal microscopy
  • Digital histopathology
  • Biomarker analysis
  • Flow cytometry

Facility management

  • Contract breeding
  • Cryopreservation and rederivation
  • Cardiac surgery
  • Stereotactic injection
  • Implantation of tumors

Customized service 

  • Medical device testing
  • Disease model development
  • Vaccine development

Therapeutic Expertise


Pkd1-cKO mouse model


  • CDX platform
  • PDX/O platform
  • Syngeneic tumor models


  • In vitro and ex vivo models
  • AD mouse models

Cardio-metabolic diseases

  • Myocardial infarction models
  • Transversal aortic constriction
  • Osmotic angiotensin II
  • HFpEF model
  • Diabetic cardiomyopathy
  • NIF model

Need more information?

If you have any questions about how we can help accelerate your research,

then let us know